Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Gynecology

  Free Subscription


Articles published in Cancer

Retrieve available abstracts of 46 articles:
HTML format
Text format



Single Articles


    January 2019
  1. MAO W, Peters HL, Sutton MN, Orozco AF, et al
    The role of vascular endothelial growth factor, interleukin 8, and insulinlike growth factor in sustaining autophagic DIRAS3-induced dormant ovarian cancer xenografts.
    Cancer. 2019 Jan 8. doi: 10.1002/cncr.31935.
    PubMed     Text format     Abstract available


    December 2018
  2. TEMKIN SM, Mallen A, Bellavance E, Rubinsak L, et al
    The role of menopausal hormone therapy in women with or at risk of ovarian and breast cancers: Misconceptions and current directions.
    Cancer. 2018 Dec 20. doi: 10.1002/cncr.31911.
    PubMed     Text format     Abstract available


  3. ESKANDER RN
    Mismatch repair in endometrioid endometrial cancer: Increasing our therapeutic proficiency by capitalizing on molecular deficiency.
    Cancer. 2018 Dec 18. doi: 10.1002/cncr.31902.
    PubMed     Text format    


  4. BACKES FJ, Haag J, Cosgrove CM, Suarez A, et al
    Mismatch repair deficiency identifies patients with high-intermediate-risk (HIR) endometrioid endometrial cancer at the highest risk of recurrence: A prognostic biomarker.
    Cancer. 2018 Dec 18. doi: 10.1002/cncr.31901.
    PubMed     Text format     Abstract available


  5. PRINTZ C
    High-risk human papillomavirus test a good option for cervical cancer screening.
    Cancer. 2018;124:4591.
    PubMed     Text format    


  6. PRINTZ C
    Human papillomavirus testing may detect cervical precancer better than Papanicolaou testing.
    Cancer. 2018;124:4430-4431.
    PubMed     Text format    


    November 2018
  7. BINES J, Tevaarwerk AJ
    Baby steps: Pregnancy outcomes after human epidermal growth factor receptor 2-targeted therapy.
    Cancer. 2018 Nov 30. doi: 10.1002/cncr.31878.
    PubMed     Text format    


  8. LAITMAN Y, Michaelson-Cohen R, Levi E, Chen-Shtoyerman R, et al
    Uterine cancer in Jewish Israeli BRCA1/BRCA2 mutation carriers.
    Cancer. 2018 Nov 29. doi: 10.1002/cncr.31842.
    PubMed     Text format     Abstract available


  9. FREY MK, Kopparam RV, Ni Zhou Z, Fields JC, et al
    Prevalence of nonfounder BRCA1/2 mutations in Ashkenazi Jewish patients presenting for genetic testing at a hereditary breast and ovarian cancer center.
    Cancer. 2018 Nov 27. doi: 10.1002/cncr.31856.
    PubMed     Text format     Abstract available


  10. AHVENAINEN TV, Makinen NM, von Nandelstadh P, Vahteristo MEA, et al
    Loss of ATRX/DAXX expression and alternative lengthening of telomeres in uterine leiomyomas.
    Cancer. 2018 Nov 13. doi: 10.1002/cncr.31754.
    PubMed     Text format     Abstract available


  11. SMITH HJ, McCaw TR, Londono AI, Katre AA, et al
    The antitumor effects of entinostat in ovarian cancer require adaptive immunity.
    Cancer. 2018 Nov 13. doi: 10.1002/cncr.31761.
    PubMed     Text format     Abstract available


  12. HARTNETT KP, Mertens AC, Kramer MR, Lash TL, et al
    Pregnancy after cancer: Does timing of conception affect infant health?
    Cancer. 2018 Nov 7. doi: 10.1002/cncr.31732.
    PubMed     Text format     Abstract available


  13. PARTRIDGE AH
    Pregnancy after cancer: Timing is everything.
    Cancer. 2018 Nov 7. doi: 10.1002/cncr.31730.
    PubMed     Text format    


  14. MAILHOT VEGA RB, Balogun OD, Ishaq OF, Bray F, et al
    Estimating child mortality associated with maternal mortality from breast and cervical cancer.
    Cancer. 2018 Nov 1. doi: 10.1002/cncr.31780.
    PubMed     Text format     Abstract available


    October 2018
  15. LAMBERTINI M, Martel S, Campbell C, Guillaume S, et al
    Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2-positive early breast cancer: analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trials.
    Cancer. 2018 Oct 18. doi: 10.1002/cncr.31784.
    PubMed     Text format     Abstract available


  16. CHLEBOWSKI RT, Luo J, Anderson GL, Barrington W, et al
    Weight loss and breast cancer incidence in postmenopausal women.
    Cancer. 2018 Oct 8. doi: 10.1002/cncr.31687.
    PubMed     Text format     Abstract available


    September 2018

  17. Survivors of endometrial cancer are more likely to experience cardiovascular problems.
    Cancer. 2018;124:3633.
    PubMed     Text format    


    June 2018
  18. ARMER JS, Clevenger L, Davis LZ, Cuneo M, et al
    Life stress as a risk factor for sustained anxiety and cortisol dysregulation during the first year of survivorship in ovarian cancer.
    Cancer. 2018 Jun 15. doi: 10.1002/cncr.31570.
    PubMed     Text format     Abstract available


    May 2018
  19. DUSKA LR
    Access to quality gynecologic oncology care: A work in progress.
    Cancer. 2018 May 16. doi: 10.1002/cncr.31391.
    PubMed     Text format    


  20. SHALOWITZ DI, Huh WK
    Access to gynecologic oncology care and the network adequacy standard.
    Cancer. 2018 May 16. doi: 10.1002/cncr.31392.
    PubMed     Text format    


  21. ADAR T, Rodgers LH, Shannon KM, Yoshida M, et al
    Universal screening of both endometrial and colon cancers increases the detection of Lynch syndrome.
    Cancer. 2018 May 11. doi: 10.1002/cncr.31534.
    PubMed     Text format     Abstract available


    March 2018

  22. Erratum: Pashankar F, Hale JP, Dang H, et al. Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the Malignant Germ Cell Tumor International Collaborative. Cancer. 2016;122:230-237.
    Cancer. 2018;124:1302.
    PubMed     Text format    


    February 2018
  23. IYER NS, Cartmel B, Friedman L, Li F, et al
    Lymphedema in ovarian cancer survivors: Assessing diagnostic methods and the effects of physical activity.
    Cancer. 2018 Feb 13. doi: 10.1002/cncr.31239.
    PubMed     Text format     Abstract available


  24. PRINTZ C
    Abdominal fat linked to cancer risk in postmenopausal women.
    Cancer. 2018;124:449.
    PubMed     Text format    


    January 2018
  25. LEVINE JM, Whitton JA, Ginsberg JP, Green DM, et al
    Nonsurgical premature menopause and reproductive implications in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study.
    Cancer. 2018 Jan 16. doi: 10.1002/cncr.31121.
    PubMed     Text format     Abstract available


  26. RAZZAGHI H, Saraiya M, Thompson TD, Henley SJ, et al
    Five-year relative survival for human papillomavirus-associated cancer sites.
    Cancer. 2018;124:203-211.
    PubMed     Text format     Abstract available


    December 2017
  27. STEWART SL, Harewood R, Matz M, Rim SH, et al
    Disparities in ovarian cancer survival in the United States (2001-2009): Findings from the CONCORD-2 study.
    Cancer. 2017;123 Suppl 24:5138-5159.
    PubMed     Text format     Abstract available


  28. BENARD VB, Watson M, Saraiya M, Harewood R, et al
    Cervical cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.
    Cancer. 2017;123 Suppl 24:5119-5137.
    PubMed     Text format     Abstract available


  29. TAARNHOJ GA, Christensen IJ, Lajer H, Fuglsang K, et al
    Risk of recurrence, prognosis, and follow-up for Danish women with cervical cancer in 2005-2013: A national cohort study.
    Cancer. 2017 Dec 6. doi: 10.1002/cncr.31165.
    PubMed     Text format     Abstract available


  30. GROEN R, Abe K, Yoon HS, Li Z, et al
    Application of microscope-based scanning software (Panoptiq) for the interpretation of cervicovaginal cytology specimens.
    Cancer. 2017;125:918-925.
    PubMed     Text format     Abstract available


    November 2017
  31. PRINTZ C
    Large population study quantifies chances of pregnancy after cancer treatment.
    Cancer. 2017;123:4308.
    PubMed     Text format    


  32. LUTGENDORF SK, Thaker PH, Arevalo JM, Goodheart MJ, et al
    Biobehavioral modulation of the exosome transcriptome in ovarian carcinoma.
    Cancer. 2017 Nov 7. doi: 10.1002/cncr.31078.
    PubMed     Text format     Abstract available


    October 2017
  33. CHAD-FRIEDMAN E, Coleman S, Traeger LN, Pirl WF, et al
    Psychological distress associated with cancer screening: A systematic review.
    Cancer. 2017;123:3882-3894.
    PubMed     Text format     Abstract available


  34. NELSON RA, Lai LL
    Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer.
    Cancer. 2017;123:4013-4021.
    PubMed     Text format     Abstract available


    September 2017
  35. LE GALLO M, Rudd ML, Urick ME, Hansen NF, et al
    The FOXA2 transcription factor is frequently somatically mutated in uterine carcinosarcomas and carcinomas.
    Cancer. 2017 Sep 21. doi: 10.1002/cncr.30971.
    PubMed     Text format     Abstract available


  36. PRINJA S, Bahuguna P, Faujdar DS, Jyani G, et al
    Cost-effectiveness of human papillomavirus vaccination for adolescent girls in Punjab state: Implications for India's universal immunization program.
    Cancer. 2017;123:3253-3260.
    PubMed     Text format     Abstract available


    August 2017
  37. TRACHT JM, Davis AD, Fasciano DN, Eltoum IA, et al
    Discrepant HPV/cytology cotesting results: Are there differences between cytology-negative versus HPV-negative cervical intraepithelial neoplasia?
    Cancer. 2017 Aug 17. doi: 10.1002/cncy.21905.
    PubMed     Text format     Abstract available


  38. MOORE KN, Borghaei H, O'Malley DM, Jeong W, et al
    Phase 1 dose-escalation study of mirvetuximab soravtansine (IMGN853), a folate receptor alpha-targeting antibody-drug conjugate, in patients with solid tumors.
    Cancer. 2017;123:3080-3087.
    PubMed     Text format     Abstract available


  39. HUNG YP, Lovitch SB, Qian X
    Histiocytic sarcoma: New insights into FNA cytomorphology and molecular characteristics.
    Cancer. 2017;125:604-614.
    PubMed     Text format     Abstract available


    June 2017
  40. GE Y, Christensen P, Luna E, Armylagos D, et al
    Performance of Aptima and Cobas HPV testing platforms in detecting high-grade cervical dysplasia and cancer.
    Cancer. 2017 Jun 2. doi: 10.1002/cncy.21875.
    PubMed     Text format     Abstract available


    May 2017
  41. GUO M, Khanna A, Wang J, Dawlett MA, et al
    Three-year risk of high-grade CIN for women aged 30 years or older who undergo baseline Pap cytology and HPV co-screening.
    Cancer. 2017 May 12. doi: 10.1002/cncy.21877.
    PubMed     Text format     Abstract available


    March 2017
  42. SAMIMI G, Minasian LM
    Opportunistic salpingectomy: What about the role of the ovary in ovarian cancer?
    Cancer. 2017 Mar 23. doi: 10.1002/cncr.30525.
    PubMed     Text format    


    February 2017
  43. ZANET E, Ciancia R, Michieli M, Tirelli U, et al
    "Twistin' the night away": Fertility preservation in young adult female cancer survivors.
    Cancer. 2017;123:707-708.
    PubMed     Text format    


  44. BENEDICT C, Thom B, Friedman DN, Diotallevi D, et al
    Reply to "Twistin' the night away": Fertility preservation in young adult female cancer survivors.
    Cancer. 2017;123:708-709.
    PubMed     Text format    


  45. JACKSON SE, Steptoe A, Fisher A
    Reply to Sexual quality of life in the cancer continuum.
    Cancer. 2017;123:530-531.
    PubMed     Text format    


    December 2016
  46. GULATI R, Albertsen PC
    Insights from the PLCO trial about prostate cancer screening.
    Cancer. 2016 Dec 1. doi: 10.1002/cncr.30472.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Gynecology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: